Results 191 to 200 of about 569,386 (218)

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Caspase-11 drives macrophage hyperinflammation in models of Polg-related mitochondrial disease. [PDF]

open access: yesNat Commun
VanPortfliet JJ   +13 more
europepmc   +1 more source

Leber's hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinflammation. [PDF]

open access: yesFront Neurol
Rahimi G   +6 more
europepmc   +1 more source

Combined Alport Syndrome Type 3A and Mitochondrial Disease Presenting with a Thin Base Membrane and Overt Albuminuria. [PDF]

open access: yesIntern Med
Nakashima D   +9 more
europepmc   +1 more source

A population-based cohort study of mitochondrial disease and mental health conditions in Ontario, Canada. [PDF]

open access: yesOrphanet J Rare Dis
Rosella LC   +5 more
europepmc   +1 more source

ADSL deficiency is a secondary mitochondrial disease affecting organelle homeostasis and ERK2/AKT signaling in a linear genotype-phenotype relation.

open access: yesCell Rep
Bordi M   +30 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Mitochondrial quality control in health and in Parkinson’s disease

Physiological Reviews, 2022
Armaan Fallahi   +2 more
exaly  

Mosaic dysfunction of mitophagy in mitochondrial muscle disease

Cell Metabolism, 2022
Amy Vincent   +2 more
exaly  

Home - About - Disclaimer - Privacy